Kadimastem Founder Professor Michel Revel is still on his quest to make the world a better place

Read this wonderful article written by Avi Jorisch on the opinion page of the Jerusalem Post

The article tells the story of Michel's discovery and bringing of the drug for the treatment of MS Rebif to the world. " Today, Rebif is one of the most popular MS drugs in the world, and its sales exceed $2.5 billion dollars annually."

Kadimastem is honored to have him continue his good work and passion for finding the cure for ALS, Diabetes and other devastating neurological diseases.

Follow the link: https://www.jpost.com/Opinion/Working-for-tips-610774